{
    "organizations": [],
    "uuid": "ef65bfd766b3e1011234c0320d8eb8930a9a46b2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-txcell-names-lonza-as-its-car-treg/brief-txcell-names-lonza-as-its-car-treg-cellular-product-manufacturer-idUSFWN1T20V9",
    "ord_in_thread": 0,
    "title": "BRIEF-Txcell Names Lonza As Its Car-Treg Cellular Product Manufacturer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 31 (Reuters) - TXCELL SA:\n* TXCELL NAMES LONZA AS ITS CAR-TREG CELLULAR PRODUCT MANUFACTURER\n* LONZA PHARMA & BIOTECH TO MANUFACTURE CLINICAL BATCHES OF TXCELL’S HLA-A2 CAR-TREG CELLULAR PRODUCT FROM ITS PRODUCTION SITE IN GELEEN\n* MASTER SERVICE AGREEMENT SIGNED BETWEEN LONZA PHARMA & BIOTECH AND TXCELL FOR MANUFACTURE OF TXCELL’S HLA-A2 CAR-TREG CELLULAR PRODUCT Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-05-31T23:53:00.000+03:00",
    "crawled": "2018-05-31T21:13:23.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "txcell",
        "sa",
        "txcell",
        "name",
        "lonza",
        "cellular",
        "product",
        "manufacturer",
        "lonza",
        "pharma",
        "biotech",
        "manufacture",
        "clinical",
        "batch",
        "txcell",
        "cellular",
        "product",
        "production",
        "site",
        "geleen",
        "master",
        "service",
        "agreement",
        "signed",
        "lonza",
        "pharma",
        "biotech",
        "txcell",
        "manufacture",
        "txcell",
        "cellular",
        "product",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}